Commercially available wearable health monitors in dogs only had a very strong correlation during longer durations of time: a pilot study.

Objective: To compare a commercially available accelerometer, FitBark 2 (FitBark 2nd Generation; FitBark) with a previously validated accelerometer, Actical (Actical; Respironics Inc) during periods of activity and rest. We hypothesized that the FitBark 2 would correlate strongly with the Actical during periods of activity and rest.

Methods: 20 dogs between the ages of 1 and 9 years of variable sex, breed, and body weight were enrolled from April through August 2022 in a 1-week pilot trial.